Found: 14
Select item for more details and to access through your institution.
Palmitic acid of Musa Paradisiaca induces apoptosis through caspase-3 in human oral squamous cell carcinoma.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 19, p. 7099
- By:
- Publication type:
- Article
Surface Treatment on Physical Properties and Biocompatibility of Orthodontic Power Chains.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/6343724
- By:
- Publication type:
- Article
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 6, p. 881, doi. 10.1007/s40257-020-00555-7
- By:
- Publication type:
- Article
Replication of plastic thin film by microfeature mould in large area hot embossing.
- Published in:
- Plastics, Rubber & Composites, 2014, v. 43, n. 2, p. 39, doi. 10.1179/1743289813Y.0000000068
- By:
- Publication type:
- Article
Comparison of height replication properties of micro-injection moulding and micro-injection–compression moulding for production of microstructures on lightguiding plates.
- Published in:
- Plastics, Rubber & Composites, 2007, v. 36, n. 2, p. 77, doi. 10.1179/174328907X171244
- By:
- Publication type:
- Article
Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2*.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 6, p. 1146, doi. 10.1111/bjd.20568
- By:
- Publication type:
- Article
Immunogenicity and pharmacokinetics of guselkumab among patients with moderate‐to‐severe psoriasis in VOYAGE‐1 and VOYAGE‐2.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. e1375, doi. 10.1111/jdv.19309
- By:
- Publication type:
- Article
Super‐response to guselkumab treatment in patients with moderate‐to‐severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 12, p. 2393, doi. 10.1111/jdv.18474
- By:
- Publication type:
- Article
Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 11, p. 1940, doi. 10.1111/jdv.15012
- By:
- Publication type:
- Article
Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 9, p. 1515, doi. 10.1111/jdv.14910
- By:
- Publication type:
- Article
Analysis of Mold Insert Fabrication for the Processing of Microfluidic Chip.
- Published in:
- Polymer Engineering & Science, 2009, v. 49, n. 1, p. 104, doi. 10.1002/pen.21227
- By:
- Publication type:
- Article
A Novel Fabrication Method for the Mold Insert of Microlens Arrays by Hot Embossing Molding.
- Published in:
- Polymer Engineering & Science, 2006, v. 46, n. 12, p. 1797, doi. 10.1002/pen.20654
- By:
- Publication type:
- Article
Primary productivity of natural grass ecosystems of the tropics: a reappraisal
- Published in:
- Plant & Soil, 1989, v. 115, n. 2, p. 155, doi. 10.1007/BF02202584
- By:
- Publication type:
- Article
Efficacy of guselkumab in subpopulations of patients with moderate‐to‐severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.
- Published in:
- British Journal of Dermatology, 2018, v. 178, n. 1, p. 132, doi. 10.1111/bjd.16008
- By:
- Publication type:
- Article